View Post

Unexpected Findings on Weight Loss and Breast Cancer from International Study in JNCCN

In Clinical Trials by Barbara Jacoby

Source: National Comprehensive Cancer Network From: prnewswire.com New research in the February 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast cancer, and found a 5% weight loss in patients over two years in was associated with worse outcomes. Weight gain over the same time period did not …

View Post

After 48 Years, NCI Aims to Track Breast Cancer Recurrences

In In The News by Barbara Jacoby

By: Nick Mulcahy From: medscape.com Change to SEER Eventually Planned Patients with breast cancer want accurate information on the risk of their cancer recurring once they have completed treatment. “I would like to know the true stats of how many breast cancers come back no matter what the hell we do for treatment,” comments a typical post on a breast …

View Post

SINGLE-DOSE RADIATION THERAPY FOR BREAST CANCER REMOVES TREATMENT BARRIERS FOR UNDERSERVED BLACK WOMEN

In In The News by Barbara Jacoby

From: prnewswire.com TARGIT Collaborative Group advocates wider adoption of TARGIT-IORT to address racial disparities and reduce compliance issues Black women experience longer breast cancer treatment times and may have less access to essential radiation technology, according to a recent study published in the journal Cancer.(1) In response, the TARGIT Collaborative Group (TCG), a national cancer advocacy organization of doctors and …

View Post

Estradiol Challenge Test ‘Highly Predictive’ of Response to Endocrine Therapy in Patients With ER-Positive Breast Cancer

In Clinical Trials by Barbara Jacoby

By: Leah Lawrence From: cancertherapyadvisor.com The use of a positron emission tomography (PET)-based estradiol challenge test was found to be highly predictive of response to endocrine therapy in women with estrogen-receptor (ER)-positive breast cancer. In the phase 2 study (NCT02455453), data from which were published in Nature Communications, the investigators measured the responses to endocrine therapy by monitoring the change …

View Post

Advances in X-ray imaging can help patients with breast cancer

In In The News by Barbara Jacoby

By: University College London From: medicalxpress.com A new X-ray imaging scanner to help surgeons performing breast tumor removal surgery has been developed by UCL experts. Most breast cancer operations are what are known as conserving surgeries, which remove the cancerous tumor rather than the whole breast. Second operations are often required if the margins (edges) of the extracted tissue are …

View Post

Savvy Cooperative: People living with non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) or breast cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Description: We’re looking for folks who have been diagnosed with cancer and have received treatment in the last 12 months Eligibility Criteria: Adult who has been diagnosed with non-small cell lung cancer, small cell lung cancer or breast cancer NOTE: Only patients with verified diagnoses will be considered US resident Details: 60-minute patient experience interview From home Receive: $100 …

View Post

Phase 3 OlympiA Trial for HER2-Negative Breast Cancer Moves to Early Primary Analysis Per IDMC Recommendation

In Clinical Trials by Barbara Jacoby

By: Hannah Slater From: cancernetwork.com In the OlympiA trial, patients with high-risk HER2-negative breast cancer were randomized 1:1 to receive either olaparib or placebo for 12 months. A planned interim analysis found that the phase 3 OlympiA trial (NCT02032823) crossed the superiority boundary for its primary end point of invasive disease-free survival (iDFS) and demonstrated a sustainable, clinically relevant treatment …

View Post

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using “Universal Acting” Fibroblast Based Immunotherapy

In In The News by Barbara Jacoby

Source: FibroGenesis From: prnewswire.com Novel Approach Successfully Induces Regression of Established Tumors by Focusing Immunotherapy to Target “Achilles Heel” of Cancer FibroGenesis, a clinical stage company developing fibroblast-based therapeutic solutions for unmet medical needs, announced today new data supporting utilizing its fibroblast-based immunotherapy for successful inhibition and induction of regression in preclinical models of breast cancer and pancreatic cancer. Company …

View Post

Bard1 Life Sciences (ASX:BD1) reveals tech’s efficiency in detecting breast cancer

In Clinical Trials by Barbara Jacoby

By: Samantha Goerling From: themarketherald.com.au Australian diagnostics company Bard1 Life Sciences (BD1) has revealed its SubB2M technology can detect all stages of breast cancer from a blood sample. Research completed by the Griffith University’s Institute for Glycomics found the technology could detect the cancer with 100 per cent specificity and 95 per cent sensitivity. “A non-invasive, accurate and reliable blood test …

View Post

Congress must close gaps in insurance for breast cancer patients | PennLive letters

In In The News by Barbara Jacoby

From: pennlive.com World Cancer Day was celebrated Feb. 4, and I would like to draw attention to the often neglected survivorship issue of lymphedema. This incurable, but treatable condition affects 15% of cancer survivors overall, 40% of all breast cancer survivors as well as others, like myself, who suffer from the condition and didn’t have cancer surgery. When cancer treatments …